Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
The price for the Jazz Pharmaceuticals plc stock decreased slightly today. Compared to yesterday there is a change of -€1.300 (-0.810%).
With 35 Buy predictions and not a single Sell prediction Jazz Pharmaceuticals plc is an absolute favorite of our community.
With a target price of 176 € there is a slightly positive potential of 12.39% for Jazz Pharmaceuticals plc compared to the current price of 156.6 €.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | -0.810% | -1.043% | 11.817% | 27.007% | 8.449% | 24.148% | 13.478% |
| Repligen Corp. | -4.690% | -8.221% | -11.588% | -26.103% | -29.854% | -36.748% | -39.331% |
| Opko Health Inc. | 3.530% | 2.985% | -3.331% | -37.383% | -9.503% | -10.796% | -72.514% |
| Amicus Therapeutics Inc. | 0.000% | 0.820% | 3.361% | 52.795% | 2.500% | 14.632% | 36.667% |
Comments
Jazz Pharmaceuticals (JAZZ) had its "overweight" rating reaffirmed by Barclays PLC.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) is now covered by Barclays PLC. They set an "overweight" rating and a $224.00 price target on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its price target raised by Morgan Stanley from $225.00 to $226.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat